EN
HI
Summary
As of 25 Oct, 2026, Glaxosmithkline Pharmaceuticals stock price is ₹2404.7. During the trading session, the stock has moved between an intraday low of ₹2344.10 and an intraday high of ₹2432.80. Over the last 52 weeks, Glaxosmithkline Pharmaceuticals has traded between ₹2088.10 and ₹3120.70.
The stock has recorded a trading volume of 56,174 shares,. Its Average Traded Price (ATP) is ₹2390.68, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 10 @ ₹2404.70.
Glaxosmithkline Pharmaceuticals has an upper circuit limit of ₹2885.60 and a lower circuit limit of ₹1923.80. The total value traded stands at ₹13.43 CR, and the delivery percentage for the day is 52.16%.
The stock is currently traded with a market lot size of 1. Glaxosmithkline Pharmaceuticals also offers a dividend yield of 2.37%.
Glaxosmithkline Pharmaceuticals Share Price Chart
Glaxosmithkline Pharmaceuticals Share Key Metrics
Volume
56174.00
Market Cap
40737.07 CR
LTQ@LTP
10@2404.70
ATP
2390.68
Var Margin
15.37 %
Circuit Range
1923.8-2885.6
Delivery %
52.16 %
Value
13.43 CR
ASM/GSM
No
Market Lot
1
Glaxosmithkline Pharmaceuticals Fundamentals
P/E Ratio
38.14
P/B Ratio
16.16
Div. Yield
2.37
Sector P/E
37.75
Sector P/B
3.16
Sec. Div. Yield
0.54
Glaxosmithkline Pharmaceuticals Resistance and Support
Pivot 2440.17
Resistance
First Resistance
2458.14
Second Resistance
2482.57
Third Resistance
2500.54
Support
First Support
2415.74
Second Support
2397.77
Third Support
2373.34
Glaxosmithkline Pharmaceuticals Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Oct 23 2026 | 2432.8 | 2404.7 | -1.19% | 2432.8 | 2344.1 |
| Thu Oct 22 2026 | 2460 | 2433.69 | -1.25% | 2464.6 | 2422.19 |
| Wed Oct 21 2026 | 2460 | 2464.39 | -1.24% | 2517.89 | 2445 |
Glaxosmithkline Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-11-03 | Quarterly Results |
| 2026-08-03 | Quarterly Results |
| 2026-05-13 | Audited Results & Dividend |
| 2026-02-09 | Quarterly Results |
| 2025-11-06 | Quarterly Results |
| 2025-08-01 | Quarterly Results |
| 2025-05-13 | Audited Results & Final Dividend |
| 2025-02-14 | Quarterly Results |
| 2025-02-10 | Quarterly Results |
| 2024-10-29 | Quarterly Results & Interim Dividend |
Glaxosmithkline Pharmaceuticals News
GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Board Meeting Intimation for To Consider, Approve And Take On Record The Un-Audited Financial Results For The Second Quarter & Half Year Ended 30Th September 2026.
GlaxoSmithKline Pharmaceuticals board will meet on 3 November 2026 for financial results. The review covers the performance for the quarter ended 30 September 2026.
Oct 13 2026 16:03:49
Glaxosmithkline Pharmaceuticals Management
| Name | Position |
|---|---|
| Ajay Nadkarni | Company Secretary & Compliance Officer, Vice President – Administration, Real Estate |
| Renu Sud Karnad | Chairperson |
Glaxosmithkline Pharmaceuticals Similar Stocks
Abbott India Ltd.
25030.00
-330.00 (1.30%)
Biocon Ltd.
323.50
-6.80 (2.06%)
Ipca Laboratories Ltd.
1953.30
49.80 (2.62%)
Gland Pharma Ltd.
2826.80
-23.60 (0.83%)
Anthem Biosciences Ltd.
812.80
12.05 (1.50%)
Ajanta Pharma Ltd.
3283.90
13.30 (0.41%)
Narayana Hrudayalaya Ltd.
1646.90
-46.30 (2.73%)
Emcure Pharmaceuticals Ltd.
1770.40
-12.20 (0.68%)
Glaxosmithkline Pharmaceuticals FAQs
The Buying Price of Glaxosmithkline Pharmaceuticals share is 2404.7 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Glaxosmithkline Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Glaxosmithkline Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Glaxosmithkline Pharmaceuticals shares is 38.14. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Glaxosmithkline Pharmaceuticals shares is 16.16. Useful to assess the stock's value relative to its book value.
To assess Glaxosmithkline Pharmaceuticals’s valuation compare Sector P/E, P/B which are 37.75 & 3.16 with sector averages, along with growth rates and financial metrics.
The Market Cap of Glaxosmithkline Pharmaceuticals is 40737.07 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Glaxosmithkline Pharmaceuticals share price is 3120.70 & 2088.10. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Glaxosmithkline Pharmaceuticals belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in GLAXO
